UBS Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.1M | Sell |
|
|||||
|
2025
Q2 | $44.1M | Sell |
|
|||||
|
2025
Q1 | $55.9M | Buy |
|
|||||
|
2024
Q4 | $17.2M | Buy |
|
|||||
|
2024
Q3 | $8.35M | Buy |
|
|||||
|
2024
Q2 | $4.18M | Sell |
|
|||||
|
2024
Q1 | $3.73M | Buy |
|
|||||
|
2023
Q4 | $2.25M | Buy |
|
|||||
|
2023
Q3 | $817K | Sell |
|
|||||
|
2023
Q2 | $1.05M | Sell |
|
|||||
|
2023
Q1 | $1.27M | Sell |
|
|||||
|
2022
Q4 | $2.1M | Buy |
|
|||||
|
2022
Q3 | $154K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $21K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $21K | Buy |
|
|||||
|
2021
Q2 | $8K | Sell |
|
|||||
|
2021
Q1 | $36K | Sell |
|
|||||
|
2020
Q4 | $43K | Buy |
|
|||||
|
2020
Q3 | $10K | Sell |
|
|||||
|
2020
Q2 | $109K | Buy |
|
|||||
|
2020
Q1 | $100K | Sell |
|
|||||
|
2019
Q4 | $231K | Sell |
|
|||||
|
2019
Q3 | $286K | Buy |
|
|||||
|
2019
Q2 | $19K | Buy |
|
|||||
|
2019
Q1 | $5K | Sell |
|
|||||
|
2018
Q4 | $838K | Buy |
|
|||||
|
2018
Q3 | $41K | Sell |
|
|||||
|
2018
Q2 | $30K | Buy |
|
|||||
|
2018
Q1 | $14K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $10K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1K | Sell |
|
|||||
|
2016
Q1 | $26K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $8K | Buy |
|